Free Trial

Zacks Research Analysts Lift Earnings Estimates for Allstate

Allstate logo with Finance background

The Allstate Co. (NYSE:ALL - Free Report) - Investment analysts at Zacks Research lifted their Q2 2025 earnings per share estimates for shares of Allstate in a research note issued to investors on Wednesday, May 14th. Zacks Research analyst R. Department now expects that the insurance provider will earn $3.11 per share for the quarter, up from their prior estimate of $3.04. The consensus estimate for Allstate's current full-year earnings is $18.74 per share. Zacks Research also issued estimates for Allstate's Q3 2025 earnings at $4.33 EPS, Q4 2025 earnings at $6.69 EPS, FY2025 earnings at $17.66 EPS, Q1 2026 earnings at $5.28 EPS, Q2 2026 earnings at $4.06 EPS, Q3 2026 earnings at $4.77 EPS, Q4 2026 earnings at $7.70 EPS and FY2026 earnings at $21.80 EPS.

Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.98 by ($0.45). Allstate had a net margin of 7.28% and a return on equity of 28.20%. The firm had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. During the same period in the prior year, the company earned $5.13 EPS. The business's quarterly revenue was up 7.8% compared to the same quarter last year.

Several other equities analysts have also issued reports on the stock. JPMorgan Chase & Co. boosted their target price on shares of Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Barclays lowered their price objective on Allstate from $183.00 to $172.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. Argus upgraded shares of Allstate from a "hold" rating to a "buy" rating in a research note on Monday, March 3rd. Evercore ISI lifted their target price on Allstate from $227.00 to $230.00 and gave the stock an "outperform" rating in a research note on Thursday, May 1st. Finally, BMO Capital Markets reiterated an "outperform" rating on shares of Allstate in a research note on Friday. One research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $225.20.

Read Our Latest Stock Report on ALL

Allstate Trading Down 0.9%

NYSE ALL traded down $1.86 on Monday, reaching $208.09. The company had a trading volume of 1,058,543 shares, compared to its average volume of 1,616,070. The business has a 50 day moving average of $199.70 and a two-hundred day moving average of $195.93. Allstate has a fifty-two week low of $156.66 and a fifty-two week high of $212.91. The firm has a market cap of $55.11 billion, a price-to-earnings ratio of 12.25, a P/E/G ratio of 1.01 and a beta of 0.32. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40.

Allstate announced that its board has approved a share buyback program on Wednesday, February 26th that permits the company to buyback $1.50 billion in shares. This buyback authorization permits the insurance provider to buy up to 3% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's leadership believes its stock is undervalued.

Allstate Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Monday, March 10th were issued a dividend of $1.00 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $4.00 annualized dividend and a dividend yield of 1.92%. This is an increase from Allstate's previous quarterly dividend of $0.92. Allstate's dividend payout ratio is 27.32%.

Hedge Funds Weigh In On Allstate

Hedge funds have recently modified their holdings of the stock. Ameritas Advisory Services LLC increased its holdings in shares of Allstate by 117.3% during the fourth quarter. Ameritas Advisory Services LLC now owns 4,896 shares of the insurance provider's stock valued at $944,000 after acquiring an additional 2,643 shares in the last quarter. Los Angeles Capital Management LLC grew its holdings in shares of Allstate by 10.5% during the fourth quarter. Los Angeles Capital Management LLC now owns 508,664 shares of the insurance provider's stock valued at $98,065,000 after buying an additional 48,382 shares during the last quarter. Artemis Investment Management LLP grew its holdings in shares of Allstate by 33.3% during the fourth quarter. Artemis Investment Management LLP now owns 401,542 shares of the insurance provider's stock valued at $77,413,000 after buying an additional 100,311 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Allstate by 56.0% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 186,792 shares of the insurance provider's stock valued at $36,012,000 after buying an additional 67,032 shares during the last quarter. Finally, CIBC Asset Management Inc grew its holdings in shares of Allstate by 4.7% during the fourth quarter. CIBC Asset Management Inc now owns 40,579 shares of the insurance provider's stock valued at $7,823,000 after buying an additional 1,828 shares during the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.

About Allstate

(Get Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Earnings History and Estimates for Allstate (NYSE:ALL)

Should You Invest $1,000 in Allstate Right Now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines